Picture of Alteogen logo

196170 Alteogen Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapMomentum Trap

Momentum

Relative Strength (%)
1m+3.33%
3m+3.64%
6m+4.55%
1yr+114.86%
Volume Change (%)
10d/3m-52.43%
Price vs... (%)
52w High-19.59%
50d MA-2.86%
200d MA+8.42%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)126.28
PEG Ratio (f)2.37
EPS Growth (f)114.05%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value71.98
Price to Tang. Book121.97
Price to Free Cashflow688.6
Price to Sales191.46
EV to EBITDA762.04

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital8.18%
Return on Equity29.52%
Operating Margin22.25%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueKR₩m42,425.8438,745.9428,806.3496,522.93102,854.62223,950346,75028.61%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/a+43.02+220.64n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Alteogen EPS forecast chart

Profile Summary

Alteogen Inc. is a Korea-based company mainly engaged in the research and development of biopharmaceuticals. The Company operates biobetter business segment, which develops protein pharmaceuticals and cancer therapies, and bio similar business segment, which develops bio similar and animal medicines. The Company mainly provides growth hormone, herceptin, humira, antibodies, animal drugs and others.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
May 13th, 2008
Public Since
December 12th, 2014
No. of Shareholders
143,495
No. of Employees
46
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
53,295,120
Blurred out image of a map
Address
62, DAEJEON, 34054
Web
http://www.alteogen.com/
Phone
+82 423848780
Auditors
Samil Accounting Corp.

196170 Share Price Performance

Upcoming Events for 196170

Q1 2025 Alteogen Inc Earnings Release

Q2 2025 Alteogen Inc Earnings Release

Similar to 196170

Picture of AbClon logo

AbClon

kr flag iconKorea Exchange - KOSDAQ

Picture of ADBiotech Co logo

ADBiotech Co

kr flag iconKorea Exchange - KOSDAQ

Picture of AHN-GOOK PHARMACEUTICAL Co logo

AHN-GOOK PHARMACEUTICAL Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Aminologics Co logo

Aminologics Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Anterogen Co logo

Anterogen Co

kr flag iconKorea Exchange - KOSDAQ

FAQ